GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...
TrumpRx launched with more than 40 medications at discounted prices after negotiations with more than a dozen drug companies.
Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, customers ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...
Surescripts, a health intelligence network, unveiled a new product on Tuesday called Script Corner, which aims to improve price transparency for medications. The new product is in partnership with ...
GoodRx, a platform that tracks prescription drug use and prices across thousands of U.S. pharmacies, has become a popular tool for patients to find discounts and compare cash prices, making its data a ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more ...
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results